Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-04-24

Clinical Trial Update: Efficacy and Safety of Sibutramin-containing Drugs in Patient With Alimentary Obesity [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy and safety of sibutramin-containing drugs in patients with obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • sibutramin-containing drugs (sibutramine)

Snippet

Sponsor: Promomed, LLC | Conditions: Obesity | Phase 4 | Status: COMPLETED